Review



bms ccr2 22  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    MedChemExpress bms ccr2 22
    Transwell invasion assays using Py8119 ( A ) and 4T1 ( B ) breast cancer cells were performed using 1% serum pooled from three mice per group (young RAGE⁺/⁺, aged RAGE⁺/⁺, or aged RAGE −/− ) as the chemoattractant, and invasion was quantified after 24 h. Transwell assays assessing migration ( C ) and invasion ( D ) of Py8119 cells toward 1% serum pooled from aged RAGE⁺/⁺ mice ( n = 3) were performed in the presence of the RAGE inhibitor TTP488 (1 μM), the S100A8/9 inhibitor paquinimod (25 μM), the CCR1 inhibitor BX471 (10 μM), or the <t>CCR2</t> <t>inhibitor</t> <t>BMS-CCR2-22</t> (10 μM). Data represent mean ± SEM from four independent biological experiments. Statistical analysis: one-way ANOVA with Dunnett’s multiple-comparisons test. * p < 0.05; ** p < 0.01; *** p < 0.001; and **** p < 0.0001.
    Bms Ccr2 22, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bms+ccr2+22/BMS+CCR2+22/pmc13179327-331-42-43
    Average 94 stars, based on 2 article reviews
    bms ccr2 22 - by Bioz Stars, 2026-09
    94/100 stars

    Images

    1) Product Images from "Aging promotes a RAGE-dependent increase in breast cancer metastasis"

    Article Title: Aging promotes a RAGE-dependent increase in breast cancer metastasis

    Journal: Communications Biology

    doi: 10.1038/s42003-026-10022-4

    Transwell invasion assays using Py8119 ( A ) and 4T1 ( B ) breast cancer cells were performed using 1% serum pooled from three mice per group (young RAGE⁺/⁺, aged RAGE⁺/⁺, or aged RAGE −/− ) as the chemoattractant, and invasion was quantified after 24 h. Transwell assays assessing migration ( C ) and invasion ( D ) of Py8119 cells toward 1% serum pooled from aged RAGE⁺/⁺ mice ( n = 3) were performed in the presence of the RAGE inhibitor TTP488 (1 μM), the S100A8/9 inhibitor paquinimod (25 μM), the CCR1 inhibitor BX471 (10 μM), or the CCR2 inhibitor BMS-CCR2-22 (10 μM). Data represent mean ± SEM from four independent biological experiments. Statistical analysis: one-way ANOVA with Dunnett’s multiple-comparisons test. * p < 0.05; ** p < 0.01; *** p < 0.001; and **** p < 0.0001.
    Figure Legend Snippet: Transwell invasion assays using Py8119 ( A ) and 4T1 ( B ) breast cancer cells were performed using 1% serum pooled from three mice per group (young RAGE⁺/⁺, aged RAGE⁺/⁺, or aged RAGE −/− ) as the chemoattractant, and invasion was quantified after 24 h. Transwell assays assessing migration ( C ) and invasion ( D ) of Py8119 cells toward 1% serum pooled from aged RAGE⁺/⁺ mice ( n = 3) were performed in the presence of the RAGE inhibitor TTP488 (1 μM), the S100A8/9 inhibitor paquinimod (25 μM), the CCR1 inhibitor BX471 (10 μM), or the CCR2 inhibitor BMS-CCR2-22 (10 μM). Data represent mean ± SEM from four independent biological experiments. Statistical analysis: one-way ANOVA with Dunnett’s multiple-comparisons test. * p < 0.05; ** p < 0.01; *** p < 0.001; and **** p < 0.0001.

    Techniques Used: Migration

    Related Articles

    Inhibition:

    Article Title: Aging promotes a RAGE-dependent increase in breast cancer metastasis
    Article Snippet: .. Where indicated, inhibitors were added directly to both upper and lower chambers at the time of plating: 1 μM TTP488 (MedChemExpress) for RAGE inhibition, 25 μM Paquinimod (Cayman Chemicals) for S100A8/9 blockade, 10 μM BX471 (MedChemExpress) for CCR1 inhibition, or 10 μM BMS-CCR2-22 (MedChemExpress) for CCR2 inhibition. ..



    Similar Products

    94
    MedChemExpress bms ccr2 22
    Transwell invasion assays using Py8119 ( A ) and 4T1 ( B ) breast cancer cells were performed using 1% serum pooled from three mice per group (young RAGE⁺/⁺, aged RAGE⁺/⁺, or aged RAGE −/− ) as the chemoattractant, and invasion was quantified after 24 h. Transwell assays assessing migration ( C ) and invasion ( D ) of Py8119 cells toward 1% serum pooled from aged RAGE⁺/⁺ mice ( n = 3) were performed in the presence of the RAGE inhibitor TTP488 (1 μM), the S100A8/9 inhibitor paquinimod (25 μM), the CCR1 inhibitor BX471 (10 μM), or the <t>CCR2</t> <t>inhibitor</t> <t>BMS-CCR2-22</t> (10 μM). Data represent mean ± SEM from four independent biological experiments. Statistical analysis: one-way ANOVA with Dunnett’s multiple-comparisons test. * p < 0.05; ** p < 0.01; *** p < 0.001; and **** p < 0.0001.
    Bms Ccr2 22, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bms+ccr2+22/BMS+CCR2+22/pmc13179327-331-42-43
    Average 94 stars, based on 1 article reviews
    bms ccr2 22 - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress ccr2 inhibitor
    Transwell invasion assays using Py8119 ( A ) and 4T1 ( B ) breast cancer cells were performed using 1% serum pooled from three mice per group (young RAGE⁺/⁺, aged RAGE⁺/⁺, or aged RAGE −/− ) as the chemoattractant, and invasion was quantified after 24 h. Transwell assays assessing migration ( C ) and invasion ( D ) of Py8119 cells toward 1% serum pooled from aged RAGE⁺/⁺ mice ( n = 3) were performed in the presence of the RAGE inhibitor TTP488 (1 μM), the S100A8/9 inhibitor paquinimod (25 μM), the CCR1 inhibitor BX471 (10 μM), or the <t>CCR2</t> <t>inhibitor</t> <t>BMS-CCR2-22</t> (10 μM). Data represent mean ± SEM from four independent biological experiments. Statistical analysis: one-way ANOVA with Dunnett’s multiple-comparisons test. * p < 0.05; ** p < 0.01; *** p < 0.001; and **** p < 0.0001.
    Ccr2 Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bms+ccr2+22/BMS+CCR2+22/10__1172_slash_jci196108-236-35-54
    Average 94 stars, based on 1 article reviews
    ccr2 inhibitor - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    93
    Tocris ccr2 antagonist
    Transwell invasion assays using Py8119 ( A ) and 4T1 ( B ) breast cancer cells were performed using 1% serum pooled from three mice per group (young RAGE⁺/⁺, aged RAGE⁺/⁺, or aged RAGE −/− ) as the chemoattractant, and invasion was quantified after 24 h. Transwell assays assessing migration ( C ) and invasion ( D ) of Py8119 cells toward 1% serum pooled from aged RAGE⁺/⁺ mice ( n = 3) were performed in the presence of the RAGE inhibitor TTP488 (1 μM), the S100A8/9 inhibitor paquinimod (25 μM), the CCR1 inhibitor BX471 (10 μM), or the <t>CCR2</t> <t>inhibitor</t> <t>BMS-CCR2-22</t> (10 μM). Data represent mean ± SEM from four independent biological experiments. Statistical analysis: one-way ANOVA with Dunnett’s multiple-comparisons test. * p < 0.05; ** p < 0.01; *** p < 0.001; and **** p < 0.0001.
    Ccr2 Antagonist, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bms+ccr2+22/BMS+CCR2+22/pm40858671-54-43-48
    Average 93 stars, based on 1 article reviews
    ccr2 antagonist - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    Tocris bmsccr2
    Transwell invasion assays using Py8119 ( A ) and 4T1 ( B ) breast cancer cells were performed using 1% serum pooled from three mice per group (young RAGE⁺/⁺, aged RAGE⁺/⁺, or aged RAGE −/− ) as the chemoattractant, and invasion was quantified after 24 h. Transwell assays assessing migration ( C ) and invasion ( D ) of Py8119 cells toward 1% serum pooled from aged RAGE⁺/⁺ mice ( n = 3) were performed in the presence of the RAGE inhibitor TTP488 (1 μM), the S100A8/9 inhibitor paquinimod (25 μM), the CCR1 inhibitor BX471 (10 μM), or the <t>CCR2</t> <t>inhibitor</t> <t>BMS-CCR2-22</t> (10 μM). Data represent mean ± SEM from four independent biological experiments. Statistical analysis: one-way ANOVA with Dunnett’s multiple-comparisons test. * p < 0.05; ** p < 0.01; *** p < 0.001; and **** p < 0.0001.
    Bmsccr2, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bms+ccr2+22/BMS+CCR2+22/pmc12071771-213-19-23
    Average 93 stars, based on 1 article reviews
    bmsccr2 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    90
    R&D Systems Hematology bms ccr2 22
    Transwell invasion assays using Py8119 ( A ) and 4T1 ( B ) breast cancer cells were performed using 1% serum pooled from three mice per group (young RAGE⁺/⁺, aged RAGE⁺/⁺, or aged RAGE −/− ) as the chemoattractant, and invasion was quantified after 24 h. Transwell assays assessing migration ( C ) and invasion ( D ) of Py8119 cells toward 1% serum pooled from aged RAGE⁺/⁺ mice ( n = 3) were performed in the presence of the RAGE inhibitor TTP488 (1 μM), the S100A8/9 inhibitor paquinimod (25 μM), the CCR1 inhibitor BX471 (10 μM), or the <t>CCR2</t> <t>inhibitor</t> <t>BMS-CCR2-22</t> (10 μM). Data represent mean ± SEM from four independent biological experiments. Statistical analysis: one-way ANOVA with Dunnett’s multiple-comparisons test. * p < 0.05; ** p < 0.01; *** p < 0.001; and **** p < 0.0001.
    Bms Ccr2 22, supplied by R&D Systems Hematology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bms+ccr2+22/anti+ccr3+fitc/pm39332444-217-46-64
    Average 90 stars, based on 1 article reviews
    bms ccr2 22 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    93
    Tocris ccr2 inhibitors bms ccr2 22
    Effect of DSF on monocyte migration in vitro. ( A ) Schematic diagram of the Boyden chamber-based monocyte chemotaxis assay toward lung cell culture supernatant (LCCS). Monocytes in input cells and migrated cells were quantified by flow cytometry, and the migration efficiency (number of monocytes in migrated cells/number of monocytes in input cells [%]) was calculated. ( B ) Migration efficiency of monocytes after <t>CCR2</t> inhibitor (BMS CCR2 22) pretreatment. n = 3 or 4 per group. ( C ) Concentrations of 13 chemokines (CXCL1, CXCL5, CXCL9, CXCL10, CXCL13, CCL2, CCL3, CCL4, CCL5, CCL11, CCL17, CCL20, and CCL22) as migration factors in the supernatant of lung tissue-derived cells of C57BL/6J mice after 72 h of culture. ( D ) Migration efficiency of monocytes pretreated with DSF, DDC, Cu(DDC) 2 , and cyanamide (ALDH inhibitor). n = 3 per group. ( E ) Percentage of viable bone marrow cells pretreated with DSF, DDC, Cu(DDC) 2 , and cyanamide (ALDH inhibitor). The percentage of viable cells not treated with inhibitors was used as the reference (100%). n = 3 per group. * P < 0.05, ** P < 0.01 (Tukey’s test).
    Ccr2 Inhibitors Bms Ccr2 22, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bms+ccr2+22/BMS+CCR2+22/pmc11464646-52-18-23
    Average 93 stars, based on 1 article reviews
    ccr2 inhibitors bms ccr2 22 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    90
    Tocris bms ccr2 22
    Effect of DSF on monocyte migration in vitro. ( A ) Schematic diagram of the Boyden chamber-based monocyte chemotaxis assay toward lung cell culture supernatant (LCCS). Monocytes in input cells and migrated cells were quantified by flow cytometry, and the migration efficiency (number of monocytes in migrated cells/number of monocytes in input cells [%]) was calculated. ( B ) Migration efficiency of monocytes after <t>CCR2</t> inhibitor (BMS CCR2 22) pretreatment. n = 3 or 4 per group. ( C ) Concentrations of 13 chemokines (CXCL1, CXCL5, CXCL9, CXCL10, CXCL13, CCL2, CCL3, CCL4, CCL5, CCL11, CCL17, CCL20, and CCL22) as migration factors in the supernatant of lung tissue-derived cells of C57BL/6J mice after 72 h of culture. ( D ) Migration efficiency of monocytes pretreated with DSF, DDC, Cu(DDC) 2 , and cyanamide (ALDH inhibitor). n = 3 per group. ( E ) Percentage of viable bone marrow cells pretreated with DSF, DDC, Cu(DDC) 2 , and cyanamide (ALDH inhibitor). The percentage of viable cells not treated with inhibitors was used as the reference (100%). n = 3 per group. * P < 0.05, ** P < 0.01 (Tukey’s test).
    Bms Ccr2 22, supplied by Tocris, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bms+ccr2+22/ccr2+antagonist+rs504393/pmc10680698__media___1-34-19-3
    Average 90 stars, based on 1 article reviews
    bms ccr2 22 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    93
    Tocris bms ccr2 22 tocris 3129 dmso sigma aldrich d2650 q5 site directed mutagenesis kit new england biolabs e0554s plasmids v2 camyel
    Effect of DSF on monocyte migration in vitro. ( A ) Schematic diagram of the Boyden chamber-based monocyte chemotaxis assay toward lung cell culture supernatant (LCCS). Monocytes in input cells and migrated cells were quantified by flow cytometry, and the migration efficiency (number of monocytes in migrated cells/number of monocytes in input cells [%]) was calculated. ( B ) Migration efficiency of monocytes after <t>CCR2</t> inhibitor (BMS CCR2 22) pretreatment. n = 3 or 4 per group. ( C ) Concentrations of 13 chemokines (CXCL1, CXCL5, CXCL9, CXCL10, CXCL13, CCL2, CCL3, CCL4, CCL5, CCL11, CCL17, CCL20, and CCL22) as migration factors in the supernatant of lung tissue-derived cells of C57BL/6J mice after 72 h of culture. ( D ) Migration efficiency of monocytes pretreated with DSF, DDC, Cu(DDC) 2 , and cyanamide (ALDH inhibitor). n = 3 per group. ( E ) Percentage of viable bone marrow cells pretreated with DSF, DDC, Cu(DDC) 2 , and cyanamide (ALDH inhibitor). The percentage of viable cells not treated with inhibitors was used as the reference (100%). n = 3 per group. * P < 0.05, ** P < 0.01 (Tukey’s test).
    Bms Ccr2 22 Tocris 3129 Dmso Sigma Aldrich D2650 Q5 Site Directed Mutagenesis Kit New England Biolabs E0554s Plasmids V2 Camyel, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bms+ccr2+22/BMS+CCR2+22/pmc10680698__media___1-34-0-3
    Average 93 stars, based on 1 article reviews
    bms ccr2 22 tocris 3129 dmso sigma aldrich d2650 q5 site directed mutagenesis kit new england biolabs e0554s plasmids v2 camyel - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    Image Search Results


    Transwell invasion assays using Py8119 ( A ) and 4T1 ( B ) breast cancer cells were performed using 1% serum pooled from three mice per group (young RAGE⁺/⁺, aged RAGE⁺/⁺, or aged RAGE −/− ) as the chemoattractant, and invasion was quantified after 24 h. Transwell assays assessing migration ( C ) and invasion ( D ) of Py8119 cells toward 1% serum pooled from aged RAGE⁺/⁺ mice ( n = 3) were performed in the presence of the RAGE inhibitor TTP488 (1 μM), the S100A8/9 inhibitor paquinimod (25 μM), the CCR1 inhibitor BX471 (10 μM), or the CCR2 inhibitor BMS-CCR2-22 (10 μM). Data represent mean ± SEM from four independent biological experiments. Statistical analysis: one-way ANOVA with Dunnett’s multiple-comparisons test. * p < 0.05; ** p < 0.01; *** p < 0.001; and **** p < 0.0001.

    Journal: Communications Biology

    Article Title: Aging promotes a RAGE-dependent increase in breast cancer metastasis

    doi: 10.1038/s42003-026-10022-4

    Figure Lengend Snippet: Transwell invasion assays using Py8119 ( A ) and 4T1 ( B ) breast cancer cells were performed using 1% serum pooled from three mice per group (young RAGE⁺/⁺, aged RAGE⁺/⁺, or aged RAGE −/− ) as the chemoattractant, and invasion was quantified after 24 h. Transwell assays assessing migration ( C ) and invasion ( D ) of Py8119 cells toward 1% serum pooled from aged RAGE⁺/⁺ mice ( n = 3) were performed in the presence of the RAGE inhibitor TTP488 (1 μM), the S100A8/9 inhibitor paquinimod (25 μM), the CCR1 inhibitor BX471 (10 μM), or the CCR2 inhibitor BMS-CCR2-22 (10 μM). Data represent mean ± SEM from four independent biological experiments. Statistical analysis: one-way ANOVA with Dunnett’s multiple-comparisons test. * p < 0.05; ** p < 0.01; *** p < 0.001; and **** p < 0.0001.

    Article Snippet: Where indicated, inhibitors were added directly to both upper and lower chambers at the time of plating: 1 μM TTP488 (MedChemExpress) for RAGE inhibition, 25 μM Paquinimod (Cayman Chemicals) for S100A8/9 blockade, 10 μM BX471 (MedChemExpress) for CCR1 inhibition, or 10 μM BMS-CCR2-22 (MedChemExpress) for CCR2 inhibition.

    Techniques: Migration

    Effect of DSF on monocyte migration in vitro. ( A ) Schematic diagram of the Boyden chamber-based monocyte chemotaxis assay toward lung cell culture supernatant (LCCS). Monocytes in input cells and migrated cells were quantified by flow cytometry, and the migration efficiency (number of monocytes in migrated cells/number of monocytes in input cells [%]) was calculated. ( B ) Migration efficiency of monocytes after CCR2 inhibitor (BMS CCR2 22) pretreatment. n = 3 or 4 per group. ( C ) Concentrations of 13 chemokines (CXCL1, CXCL5, CXCL9, CXCL10, CXCL13, CCL2, CCL3, CCL4, CCL5, CCL11, CCL17, CCL20, and CCL22) as migration factors in the supernatant of lung tissue-derived cells of C57BL/6J mice after 72 h of culture. ( D ) Migration efficiency of monocytes pretreated with DSF, DDC, Cu(DDC) 2 , and cyanamide (ALDH inhibitor). n = 3 per group. ( E ) Percentage of viable bone marrow cells pretreated with DSF, DDC, Cu(DDC) 2 , and cyanamide (ALDH inhibitor). The percentage of viable cells not treated with inhibitors was used as the reference (100%). n = 3 per group. * P < 0.05, ** P < 0.01 (Tukey’s test).

    Journal: Scientific Reports

    Article Title: Antifibrotic effect of disulfiram on bleomycin-induced lung fibrosis in mice and its impact on macrophage infiltration

    doi: 10.1038/s41598-024-71770-z

    Figure Lengend Snippet: Effect of DSF on monocyte migration in vitro. ( A ) Schematic diagram of the Boyden chamber-based monocyte chemotaxis assay toward lung cell culture supernatant (LCCS). Monocytes in input cells and migrated cells were quantified by flow cytometry, and the migration efficiency (number of monocytes in migrated cells/number of monocytes in input cells [%]) was calculated. ( B ) Migration efficiency of monocytes after CCR2 inhibitor (BMS CCR2 22) pretreatment. n = 3 or 4 per group. ( C ) Concentrations of 13 chemokines (CXCL1, CXCL5, CXCL9, CXCL10, CXCL13, CCL2, CCL3, CCL4, CCL5, CCL11, CCL17, CCL20, and CCL22) as migration factors in the supernatant of lung tissue-derived cells of C57BL/6J mice after 72 h of culture. ( D ) Migration efficiency of monocytes pretreated with DSF, DDC, Cu(DDC) 2 , and cyanamide (ALDH inhibitor). n = 3 per group. ( E ) Percentage of viable bone marrow cells pretreated with DSF, DDC, Cu(DDC) 2 , and cyanamide (ALDH inhibitor). The percentage of viable cells not treated with inhibitors was used as the reference (100%). n = 3 per group. * P < 0.05, ** P < 0.01 (Tukey’s test).

    Article Snippet: Thereafter, we incubated these cells at 25 °C for 90 min with or without various inhibitors such as CCR2 inhibitors BMS CCR2 22 (Tocris), DSF, DDC (Tokyo Chemical Industry), Cu(DDC) 2 (Tokyo Chemical Industry), and cyanamide (SIGMA), an ALDH inhibitor similar to DSF.

    Techniques: Migration, In Vitro, Chemotaxis Assay, Cell Culture, Flow Cytometry, Derivative Assay